Dr. Alasdair Russell

Dr. Alasdair Russell

Genome Editing Technologies

Dr. Alasdair Russell is head of Pre-Clinical Genome editing at CRUK Cambridge Institute.

 

Alasdair heads up a specialised team that provide a centralised ‘Hub’ for the innovation and application of state-of-the-art Genome Editing technologies to complex, patient-relevant model systems in a pre-clinical setting. Further, these novel models are used in a range of pre-clinical trials to advance understanding of disease.

 

Alasdair Russell is the Head of Pre-Clinical Genome Editing at CRUK Cambridge Institute, University of Cambridge, UK (2015-present). Alasdair's team provide a centralised ''Hub'' for the innovation and application of state-of-the-art Genome Editing (eg CRISPR/Cas9) technologies in complex, patient-relevant model systems in a pre-clinical setting. 

 

Alasdair has expertise in the creation and correction of disease models (in vivo, ex vivo and in vitro) with a strong emphasis on the translation of discoveries at the bench to tangible clinical outcomes. Alasdair also has a passion for ''blue sky'' innovation of Genome Editing technologies.  

 

As a Postdoctoral Research Fellow (2007-2014, University of Cambridge, UK), Alasdair developed a successful track record within the fields of stem cell biology and cancer (especially breast). He developed expertise in viral vectors for gene therapy, novel pre-clinical model generation and pre-clinical trials, drug repurposing, and the regulatory aspects associated with collecting and using primary human tissue and generating in vivo models.

 

Alasdair pro-actively engages across many diverse disciplines, in the Academic, Industry, and Investment sectors, and has a core passion for innovation in a cross-disciplinary environment with an entrepreneurial focus.

Events

  • CI

    CI

    Super Human You in a Super Human World: Gene Editing, Robotics and Ethics

    20th Sep 2017